MDxHealth and Sumitomo Sign Pharmaco Molecular Diagnostic Partnership for …

MDxHealth and Sumitomo Sign Pharmaco Molecular Diagnostic Partnership for …
IRVINE, CA and LIEGE, BELGIUM — (Marketwired) — 07/01/13 — MDxHealth SA (EURONEXT BRUSSELS: MDXH), a leading molecular diagnostic company that develops and commercializes epigenetic tests to support the diagnosis and treatment of cancer …. As … Read more on SYS-CON Media (press release)

Health notes: Aspirin ineffective against colon tumor with BRAF mutation
Aspirin's benefit in thwarting colon cancer is driven by a gene mutation that makes tumor cells less sensitive to the drug's effects, according to a study that may lead to personalized prevention strategies. Developing … Researchers from Stanford … Read more on Minneapolis Star Tribune